Delivery Order SPE2DB25D3020-SPE2DB25FWKQL
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packages) under a firm fixed price contract. The award, issued on September 15, 2025, with an ultimate completion date of October 6, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed-price contract valued at $12,015.80, with completion scheduled by September 9, 2025. This is a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count packaging). This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 3, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,015.80 on May 2, 2025, for the supply of Tasigna 150 mg capsules (28-count packaging). This firm fixed-price, non-set-aside contract is scheduled for completion by May 23, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (quantity: 28 units) on September 4, 2025. This firm fixed-price, competitively awarded delivery order is scheduled for completion by September 25, 2025, with fulfillment occurring at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating that AmerisourceBergen competed...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (quantity: 28 units) on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside delivery order represents a competitive award under the company's broader pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count units) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKQLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of October 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to military healthcare systems worldwide, including specialized medications across multiple therapeutic domains. The parent IDC represents AmerisourceBergen's strategic role as a key pharmaceutical prime vendor supporting the Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/16/25 |